Teduglutide Peptide: Ntev - ua yeeb yam GLP-2 analogue rau kho plab

Hauv kev kho mob ntawm plab plob tsis so tswj thiab plab hnyuv tsis ua haujlwm,Teduglutide Peptide hmoovyog lub ntiaj teb thawj zaug pom zoo ntev - ua GLP-2 analogue. Ua los ntawm 33 amino acids, nws yog npaj siv recombinant DNA technology thiab tshwm raws li ib tug dawb lyophilized hmoov. Raws li ib qho - qhov hloov kho ntawm ntuj GLP-2, nws txuas nws ib nrab ntawm lub neej los ntawm 7 feeb mus rau 2 teev vim DPP-4 enzyme tsis kam, ua kom lub hom phiaj ntawm txoj hnyuv mucosal, txhawb txoj hnyuv epithelial proliferation, txhawb kev nqus dej, thiab txo qhov kev cia siab ntawm niam txiv kev noj zaub mov tsis zoo hauv cov neeg mob.

🔬 Molecular Code of Long -Lusing GLP-2

Chemically, Teduglutide peptide yog ib qho hluavtaws analogue ntawm tib neeg glucagon-zoo li peptide-2 (GLP-2), belongs rau lub plab hnyuv endocrine hormone tsev neeg. Ntuj GLP-2 yog 33-amino acid peptide secreted los ntawm txoj hnyuv L hlwb, tso tawm postprandially. Nws lub luag haujlwm tseem ceeb yog inhibit plab hnyuv plab thiab gastric acid secretion, thiab txhawb txoj hnyuv mucosal loj hlob. Txawm li cas los xij, daim ntawv thov kev kho mob ntawm ntuj GLP-2 yog txwv los ntawm nws qhov luv luv ib nrab-lub neej-nws yog sai sai inactivated nyob rau hauv vivo los ntawm DPP-4 enzyme ntawm lub thib ob alanine residue.

 

Teduglutide peptideua tiav qhov kev hloov kho "ntev- ua" los ntawm kev hloov cov amino acid tseem ceeb ntawm N-terminus ntawm natural GLP-2. Nws hloov qhov thib ob alanine residue nyob rau hauv lub ntuj ib ntus, uas yog yooj yim tawm tsam los ntawm DPP-4, nrog glycine. Qhov kev hloov kho me me no txwv tsis pub DPP-4 los ntawm kev paub zoo thiab cleaving teduglutide, ncua nws ib nrab-lub neej mus rau 2-3 teev. Tib lub sijhawm, nws khaws cia tib yam C-terminal ib ntus raws li ntuj GLP-2, ua kom muaj kev sib raug zoo siab ntawm GLP-2 receptor. Qhov "kev hloov kho tsawg kawg nkaus" tsim lub tswv yim no zam cov teeb meem ntawm kev tiv thaiv kab mob thaum ua tiav cov yam ntxwv ntawm cov tshuaj pharmacokinetic.

 

Lub cev, siab -purity Teduglutide Peptide yog dawb los tawm-cov hmoov dawb lyophilized, feem ntau muab rau hauv daim ntawv acetic acid lossis hydrochloride. Nws qhov hnyav molecular yog kwv yees li 3750 Da, muab faib ua qhov nruab nrab - mus rau ntev - saw peptide. Nyob rau hauv cov nqe lus ntawm solubility, Teduglutide Peptide yog yooj yim soluble nyob rau hauv sterile dej thiab 0.9% sodium chloride txhaj, thiab yog npaj rau kev txhaj tshuaj subcutaneous. Cov hmoov lyophilized yuav tsum muab cia rau hauv qhov chaw txias, qhuav ntawm 2-8 degree, tiv thaiv los ntawm lub teeb. Cov tshuaj reconstituted yuav tsum tau siv tam sim ntawd los yog nyob rau hauv 24 teev ntawm 2-8 degree. Kev khov yuav tsum zam kom tsis txhob muaj peptide degradation los yog sib sau ua ke.

 

Nyob rau hauv cov nqe lus ntawm cov qauv kev faib tawm thiab nomenclature, thawj lub npe ntawm Teduglutide Peptide yog Revestive lossis Gatex. Nws belongs rau "GLP-2 receptor agonist" qeb ntawm cov tshuaj peptide, koom nrog tib lub tsev neeg zoo li GLP-1 receptor agonists, tab sis nrog cov hom phiaj sib txawv thiab cov tshuaj kho mob. Raws li cov khoom siv peptide, cov tshuaj no feem ntau yog tsim los ntawm cov khoom siv -theem peptide synthesis thev naus laus zis thiab ua kom huv rau ntau dua 99% los ntawm kev thim rov qab-theem high-performance kua chromatography kom tau raws li kev tswj hwm nruj rau kev txhaj tshuaj subcutaneous.

⚙️ Tus Pro-Adaptive Logic of Intestinal Crypt Cell Proliferation

Lub ntsiab pharmacological mechanism ntawmTeduglutide peptidedag nyob rau hauv activating GLP-2 receptors nyob rau hauv cov hnyuv epithelium, pib ib tug series ntawm signaling cascades uas txhawb txoj hnyuv loj hlob thiab kho. Hauv crypt-villi axis ntawm txoj hnyuv, GLP-2 receptors feem ntau yog qhia hauv enteroendocrine hlwb thiab enteric neurons, tsis yog ncaj qha rau hauv crypt qia hlwb. Teduglutide indirectly txhawb kev loj hlob ntawm crypt qia hlwb los ntawm ib tug "tsis-cellular autonomous" mechanism.

 

Thaum Teduglutide peptide txhaj tshuaj subcutaneously, nws khi rau GLP-2 receptors nyob rau hauv cov ntaub so ntswg, pib activating enteroendocrine hlwb thiab myofibroblasts. Cov hlwb no tom qab ntawd tso tawm ntau yam kev loj hlob, suav nrog keratinocyte kev loj hlob, insulin-zoo li kev loj hlob factor-1 (IGF-1), thiab vascular endothelial kev loj hlob zoo (VEGF). IGF-1 yog suav hais tias yog ib qho tseem ceeb ntawm cov dej ntws nruab nrab los kho qhov kev loj hlob-txhim kho cov teebmeem ntawm GLP-2. Cov teeb meem paracrine no synergistically ua rau Lgr5+ qia hlwb ntawm lub hauv paus ntawm crypts, ua rau lawv hloov los ntawm lub xeev quiescent mus rau lub voj voog ntawm tes, ua kom cov qia cell faib thiab tsiv teb tsaws ntawm cov ntxhais hlwb mus rau lub tswv yim villus.

Hauv crypt-villous chav tsev ntawm txoj hnyuv me, Teduglutide peptide kev kho mob ua rau nce qhov siab ntawm villus. Nce villus qhov siab ncaj qha nthuav qhov chaw sib cuag ntawm txoj hnyuv lumen thiab ntshav, ua kom cov dej thiab cov khoom nqus nqus. Ib txhij, Teduglutide peptide tuaj yeem ncua sijhawm crypt cell apoptosis, tuav ntev -lub sij hawm homeostasis ntawm qia cell pas dej ua ke, yog li txhawb txoj hnyuv tas mus li tus kheej- rov ua dua tshiab. Hauv cov neeg mob uas muaj lub plab plob tsis so tswj, cov hnyuv me uas tseem tshuav yog nyob rau hauv lub xeev ntawm "atrophy-decompensation" vim yog qhov tsis zoo. Teduglutide tsis tsuas yog thim rov qab cov txheej txheem atrophy no xwb tab sis kuj tseem ua rau "superproliferation," tso cai rau cov plab hnyuv seem los them nrog qhov nqus dej ntxiv.

 

Teduglutide kuj tseem ua rau cov ntshav ntws hauv plab hnyuv thiab cuam tshuam kev ua haujlwm. Cov kev tshawb fawb tau pom tias GLP-2 receptor activation ua rau endothelial nitric oxide synthase, ua kom cov ntshav perfusion hauv plab hnyuv microcirculation thiab muab cov pa oxygen txaus thiab cov as-ham rau cov cell proliferating sai. Nyob rau tib lub sijhawm, nws txhawb nqa cov lus qhia ntawm cov kab sib txuas ceev ceev, txhim kho txoj hnyuv ua haujlwm thiab txo cov kab mob hloov mus, uas muaj cov txiaj ntsig tsis ncaj rau kev tiv thaiv kab mob ntsig txog catheter hauv cov neeg mob uas muaj plab plob tsis so tswj.

 

Ntawm cov txheej txheem metabolic, Teduglutide peptide tseem cuam tshuam rau plab hnyuv plab thiab gastric acid secretion. Los ntawm kev ncua lub plab khoob, nws ua rau lub sijhawm sib cuag ntawm chyme thiab cov tshuaj thiab cov hnyuv ntxiv; thaum inhibiting gastric acid secretion txo cov load ntawm lub plab zom mov sab sauv mus rau acidic ib puag ncig, uas yog qhov zoo rau kev tswj xyuas kev ncaj ncees ntawm txoj hnyuv mucosa. Txawm hais tias cov "tsis yog{2}}kev loj hlob- txhawb nqa" cov teebmeem no tsis yog lub luag haujlwm tseem ceeb ntawm cov tshuaj, lawv sib sau ua kom zoo dua qhov nqus ntawm cov hnyuv ntawm cov hnyuv.

💊Specific Clinical positioning of weaning from parenteral khoom noj khoom haus

Qhov tseem ceeb tshaj plaws thiab tsuas yog kev pom zoo siv tshuaj kho mob ntawm Teduglutide peptide thoob ntiaj teb yog rau kev kho mob ntawm cov neeg laus cov neeg laus uas muaj lub plab plob tsis so tswj (SBS) thiab cov menyuam yaus hnub nyoog 1 xyoos thiab laus dua uas xav tau cov khoom noj khoom haus parenteral. SBS cov neeg mob feem ntau muaj qhov ua haujlwm tsis txaus ntawm lub plab me me vim muaj cov kab mob mesenteric vascular, ntau qhov kev kho mob rau Crohn tus kab mob, los yog congenital malformations, ua rau nws tsis yooj yim sua kom tswj tau cov as-ham.

 

Cov tshuaj no tsis haum rau cov neeg mob uas muaj malabsorption vim yog mob malignancies, tsis kho Crohn tus kab mob, los yog plab hnyuv strictures. Cov txheej txheem kho mob tseem pom zoo tias Teduglutide peptide yuav tsum tau siv raws li kev taw qhia ntawm pab pawg neeg noj zaub mov tshwj xeeb thiab ua ke nrog kev hloov kho tus kheej rau kev noj zaub mov zoo. Hauv cov kev sim tshuaj classic III, cov neeg mob hauv Teduglutide peptide pab pawg kho mob tau pom tias muaj kev txo qis ntau dua ntawm cov khoom noj khoom haus parenteral los ntawm qhov pib ntawm lub lim tiam 24 piv rau cov placebo pawg. Cov kauj ruam-2 qhib- cov ntawv tshawb fawb txuas ntxiv tau lees paub qhov kev ua tau zoo ntawm lub sijhawm ntev - cov tshuaj no-qee cov neeg mob txawm tias tag nrho cov khoom noj khoom haus parenteral.

 

Hais txog kev siv tshuaj noj thiab ntau npaum li cas rau cov neeg mob laus, tus qauv noj tshuaj rau teduglutide yog ib hnub ib zaug ntawm kev txhaj tshuaj subcutaneous. Cov chaw txhaj tshuaj tuaj yeem tig nruab nrab ntawm lub plab, ncej puab, lossis sab caj npab. Hauv cov neeg mob menyuam yaus, cov koob tshuaj pom zoo kuj tseem yog 0.05 mg / kg lub cev hnyav ib zaug ib hnub, tab sis cov tshuaj yuav tsum tau kos kom raug siv cov tshuaj insulin tshwj xeeb lossis 0.5 mL microsyringe.Teduglutide Peptide hmoovfeem ntau tsis pom zoo siv thaum cev xeeb tub lossis pub niam mis.

 

Hais txog kev txiav txim siab tshwj xeeb rau kev siv menyuam yaus, ib txoj kev tshawb fawb 2024 luam tawm hauv Clinical Nutrition suav nrog cov menyuam yaus uas muaj lub plab plob tsis so tswj (SBS). Cov ntaub ntawv qhia tau hais tias tom qab 24 lub lis piam ntawm kev kho mob, cov me nyuam cov khoom noj khoom haus parenteral yuav tsum tau txo qis, thiab qee cov me nyuam tau ua tiav kev txiav tawm los ntawm kev noj zaub mov ntawm niam txiv. Txoj kev tshawb no kuj tau soj ntsuam cov me nyuam txoj kev loj hlob thiab tsis pom cov tshuaj- cuam tshuam txog kev loj hlob txawv txav, qhia tias teduglutide Peptide muaj kev pheej hmoo zoo- qhov txiaj ntsig piv rau kev tswj hwm SBS hauv cov menyuam yaus.

 

Hais txog cov yam ntxwv kev nyab xeeb, teduglutide Peptide feem ntau zam tau zoo, tab sis cov kev pheej hmoo tshwj xeeb xav tau kev saib xyuas. Cov xwm txheej tshwm sim feem ntau muaj xws li xeev siab, mob plab, qhov chaw txhaj tshuaj, thiab mob plab. Vim hais tias cov tshuaj no txhawb txoj hnyuv loj hlob, muaj kev pheej hmoo ntawm intussusception, plab hnyuv, thiab kev loj hlob ntawm polyps los yog qog. Yog li ntawd, tom qab- kev soj ntsuam kev lag luam yuav tsum tau ua raws li niaj zaus- ntawm cov neeg mob.

🔭 Ib Tus Tshiab Frontier hauv Growth Factor Synergy thiab Tissue Engineering

Nyob rau hauv xyoo tas los no, kev tshawb fawb soj ntsuam ntawm Teduglutide peptide tau nthuav dav los ntawm kev txo cov khoom noj khoom haus parenteral mus rau ntau dua hauv - qhov tob xws li kev txiav kom tiav los ntawm cov khoom noj khoom haus parenteral thiab cov khoom siv hauv plab hnyuv. Hais txog cov tswv yim kho mob ua ke, cov kws kho mob tab tom tshawb nrhiav kev sib txuas lossis ua ke ntawm Teduglutide peptide thiab kev loj hlob hormone. Kev loj hlob hormone kuj txhawb nqa protein synthesis thiab plab hnyuv adaptation. Hauv qee cov neeg mob, kev sib xyaw ntawm ob cov tshuaj tuaj yeem ua rau muaj kev sib koom ua ke.

Raws li lub superproliferation induced los ntawm Teduglutide peptide, cov kws tshawb fawb tau tsim ib tug tshiab autologous plab hnyuv cov ntaub so ntswg engineering tswv yim. Cov txheej txheem no ua ntej "cultures" txheej txheej plab hnyuv tshiab sab nraum cov hnyuv me, thiab tom qab ntawd hloov nws rov qab rau hauv tus neeg mob siv cov txheej txheem autologous cov ntaub so ntswg engineering.Teduglutide peptideua raws li "in vitro expansion promoter," ua raws li kev loj hlob vivo- txhawb nqa cov cim hauv kab lis kev cai nruab nrab kom ua rau cov kab mob hauv plab hnyuv loj, uas ib txwm nyuaj rau kab lis kev cai ntev - lub sij hawm hauv vitro, tsim cov kab mob hauv plab. Hom "organoid-scaffold" complex no tau qhia txog lub peev xwm los tsim kho lub plab hnyuv epithelium hauv cov qauv tsiaj.

 

Nyob rau hauv lub sij hawm ntev - kev tswj cov neeg laus lub plab plob tsis so tswj syndrome, lub tswv yim tshem tawm ntawm Teduglutide peptide kev kho mob kuj yog ib qho tseem ceeb ntawm kev kho mob. Nws feem ntau ntseeg tau tias thaum tus neeg mob cov khoom noj khoom haus parenteral tau txo qis qis heev (xws li, tsuas yog 1-2 hnub hauv ib lub lis piam) thiab qhov hnyav thiab qib albumin tuaj yeem tswj tau kom ruaj khov, kev ceev faj txog kev maj mam txo cov tshuaj tuaj yeem sim. Txawm li cas los xij, vim tias qhov siab villous yuav maj mam poob tom qab txiav tawm, qee cov neeg mob tseem xav tau kev kho mob tas mus li.

 

Hauv thaj chaw ntawm kev kho mob plab hnyuv tsis ua haujlwm rau menyuam yaus, Teduglutide peptide tau muab tso rau hauv qhov kev pabcuam dav dav ntawm cov chaw kho mob plab hnyuv rau menyuam yaus. Qhov kev pabcuam no suav nrog kev txhawb nqa zaub mov, kev tswj lub plab microbiota, micronutrient supplementation, thiab teduglutide pharmacological therapy. Raws li tus qauv no, qhov kev vam meej ntawm kev txiav cov menyuam yaus tawm ntawm cov khoom noj khoom haus parenteral tuaj yeem txhim kho tau zoo. Ib txoj kev tshawb fawb 2024 kuj tau qhia tshwj xeeb tias rau kev tsim cov menyuam yaus, kev loj hlob ntawm lawv cov txha nqaj qaum thiab cov pob qij txha yuav tsum tau saib xyuas thaum kho teduglutide, vim GLP-2 receptor activation tuaj yeem cuam tshuam rau pob txha loj hlob.

 

Nyob rau hauv cov khoom siv tshuaj nquag (API) kev lag luam saw, Teduglutide peptide, raws li qib siab -tus nqi- ntxiv cov tshuaj peptide, muaj cov txheej txheem sib xyaw ua ke thiab cov qauv tswj kom zoo. Kev tiv thaiv patent muab los ntawm Takeda Pharmaceutical, thawj cov chaw tsim khoom, tau tsim cov txheej txheem siab rau cov tshuaj no. Nrog rau qhov tas sij hawm ntawm patents tseem ceeb hauv kev lag luam thoob ntiaj teb, ntau lub tuam txhab tshuaj generic tau pib tsim biosimilars ntawmTeduglutide Peptide hmoov. Generic versions ntawm Teduglutide yuav tsum tau ua kom tiav kev sib piv nrog cov thawj tshuaj nyob rau hauv cov nqe lus ntawm cov qauv, purity, bioactivity, thiab soj ntsuam sib npaug. Raws li kev paub txog kev mob plab hnyuv loj zuj zus ntxiv thiab kev siv tshuaj nkag tau zoo hauv Suav teb, kev nkag mus rau kev ua lag luam ntawm Teduglutide yuav nce ntxiv.

🧬 Xaus

Kev tshuaj xyuas Teduglutide Peptide los ntawm kev sib koom ua ke ntawm cov tshuaj peptide thiab digestive physiology, nws yog ib tug kab mob uas ua tiav "ntev{0}} ntev" cov teebmeem thiab ua rau lub plab hnyuv tus kheej- kho mechanism los ntawm "kev hloov kho meej." Nws txoj cai molecular nyob rau hauv kev hloov ntawm glycine ntawm txoj hauj lwm 2-qhov no ib leeg- taw tes amino acid kev hloov pauv los ntawm kev kho mob daim ntawv thov bottleneck ntawm lub luv luv ib nrab-lub neej ntawm ntuj GLP-2.

 

Peb paub tias kev sib txuas ntawm cov khoom siv sib xws yog qhov tseem ceeb hauv kev sib tw ua lag luam raws li qhov zoo tshaj plawsTeduglutide Peptide hmoovtus muab kev pab. Peb cov txheej txheem tsim khoom thiab cov khoom lag luam tswj xyuas cov khoom xa tuaj txawm tias hloov pauv. Tshawb nrhiav peb cov khoom lag luam nthuav dav thiab sib tham txog koj cov kev xav tau kev yuav khoom nrog peb cov kws tshaj lij ntawmallen@faithfulbio.com.